Search

Redentor M. Pasia

Examiner (ID: 16815, Phone: (571)272-9745 , Office: P/2479 )

Most Active Art Unit
2413
Art Unit(s)
2616, 2413, 2474, 2479, 2416
Total Applications
771
Issued Applications
563
Pending Applications
74
Abandoned Applications
158

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8465095 [patent_doc_number] => 20120270264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'DNA CONSTRUCT, AND PROCESS FOR PRODUCTION OF RECOMBINANT CHO CELL USING SAME' [patent_app_type] => utility [patent_app_number] => 13/498006 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13699 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498006 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/498006
DNA CONSTRUCT, AND PROCESS FOR PRODUCTION OF RECOMBINANT CHO CELL USING SAME Sep 20, 2010 Abandoned
Array ( [id] => 6353792 [patent_doc_number] => 20100331523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Heterologous Protein Production Using The Twin Arginine Translocation Pathway' [patent_app_type] => utility [patent_app_number] => 12/874785 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16462 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331523.pdf [firstpage_image] =>[orig_patent_app_number] => 12874785 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/874785
Heterologous Protein Production Using The Twin Arginine Translocation Pathway Sep 1, 2010 Abandoned
Array ( [id] => 8265798 [patent_doc_number] => 20120165220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Uses of CD116 Expression Level' [patent_app_type] => utility [patent_app_number] => 13/393585 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8234 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393585 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/393585
Uses of CD116 Expression Level Aug 30, 2010 Abandoned
Array ( [id] => 11298118 [patent_doc_number] => 09506114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => 'Identifying genetic variation in affected tissues' [patent_app_type] => utility [patent_app_number] => 13/392776 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13261 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392776 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/392776
Identifying genetic variation in affected tissues Aug 25, 2010 Issued
Array ( [id] => 6070045 [patent_doc_number] => 20110044895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR REDUCING STEMNESS IN ONCOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/852973 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23159 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044895.pdf [firstpage_image] =>[orig_patent_app_number] => 12852973 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/852973
METHODS AND COMPOSITIONS FOR REDUCING STEMNESS IN ONCOGENESIS Aug 8, 2010 Abandoned
Array ( [id] => 11256998 [patent_doc_number] => 09481893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-01 [patent_title] => 'DNA capable of inducing osteoblast-specific expression' [patent_app_type] => utility [patent_app_number] => 13/389204 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 11808 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389204 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/389204
DNA capable of inducing osteoblast-specific expression Aug 5, 2010 Issued
Array ( [id] => 10182695 [patent_doc_number] => 09212367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-15 [patent_title] => 'Methods for improving recombinant protein expression' [patent_app_type] => utility [patent_app_number] => 13/390297 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 7779 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390297 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/390297
Methods for improving recombinant protein expression Aug 5, 2010 Issued
Array ( [id] => 8290318 [patent_doc_number] => 20120178647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'ENGINEERING OF ZINC FINGER ARRAYS BY CONTEXT-DEPENDENT ASSEMBLY' [patent_app_type] => utility [patent_app_number] => 13/386995 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22039 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386995 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/386995
ENGINEERING OF ZINC FINGER ARRAYS BY CONTEXT-DEPENDENT ASSEMBLY Aug 2, 2010 Abandoned
Array ( [id] => 8265793 [patent_doc_number] => 20120165216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'METHOD FOR IDENTIFYING SENESCENT MESENCHYMAL STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/387694 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10165 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387694 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/387694
METHOD FOR IDENTIFYING SENESCENT MESENCHYMAL STEM CELLS Jul 29, 2010 Abandoned
Array ( [id] => 8313544 [patent_doc_number] => 20120190573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'BIOMARKER OF LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 13/378654 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15410 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378654 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/378654
BIOMARKER OF LUNG CANCER Jul 26, 2010 Abandoned
Array ( [id] => 6622999 [patent_doc_number] => 20100311107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Ultra-High Throughput Screening of Natural Products' [patent_app_type] => utility [patent_app_number] => 12/844046 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23048 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311107.pdf [firstpage_image] =>[orig_patent_app_number] => 12844046 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/844046
Ultra-High Throughput Screening of Natural Products Jul 26, 2010 Abandoned
Array ( [id] => 8199237 [patent_doc_number] => 20120122726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'MARKERS FOR ENDOMETRIAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/386536 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 67109 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 51 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122726.pdf [firstpage_image] =>[orig_patent_app_number] => 13386536 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/386536
Markers for endometrial cancer Jul 22, 2010 Issued
Array ( [id] => 10857251 [patent_doc_number] => 08883446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Human long pentraxin 3 expression system and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/387784 [patent_app_country] => US [patent_app_date] => 2010-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5338 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387784 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/387784
Human long pentraxin 3 expression system and uses thereof Jul 19, 2010 Issued
Array ( [id] => 10553915 [patent_doc_number] => 09278108 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-08 [patent_title] => 'HMGB1 binding nucleic acid molecule and applications thereof' [patent_app_type] => utility [patent_app_number] => 13/383826 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 22173 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383826 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/383826
HMGB1 binding nucleic acid molecule and applications thereof Jul 15, 2010 Issued
Array ( [id] => 6198318 [patent_doc_number] => 20110030076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Methods and compositions for targeted cleavage and recombination' [patent_app_type] => utility [patent_app_number] => 12/804234 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 46123 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20110030076.pdf [firstpage_image] =>[orig_patent_app_number] => 12804234 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/804234
Methods and compositions for targeted cleavage and recombination Jul 15, 2010 Issued
Array ( [id] => 5992963 [patent_doc_number] => 20110014616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Rapid screening of biologically active nucleases and isolation of nuclease-modified cells' [patent_app_type] => utility [patent_app_number] => 12/803552 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14819 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014616.pdf [firstpage_image] =>[orig_patent_app_number] => 12803552 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/803552
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells Jun 28, 2010 Abandoned
Array ( [id] => 8252348 [patent_doc_number] => 20120156672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'NOVEL STRINGENT SELECTABLE MARKERS' [patent_app_type] => utility [patent_app_number] => 13/378006 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22287 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156672.pdf [firstpage_image] =>[orig_patent_app_number] => 13378006 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/378006
Stringent selectable markers Jun 14, 2010 Issued
Array ( [id] => 11888275 [patent_doc_number] => 09758827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'miRNA fingerprint in the diagnosis of lung cancer' [patent_app_type] => utility [patent_app_number] => 13/376281 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 104 [patent_figures_cnt] => 25 [patent_no_of_words] => 14069 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376281 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/376281
miRNA fingerprint in the diagnosis of lung cancer Jun 6, 2010 Issued
Array ( [id] => 6292739 [patent_doc_number] => 20100239608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS' [patent_app_type] => utility [patent_app_number] => 12/787755 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10680 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239608.pdf [firstpage_image] =>[orig_patent_app_number] => 12787755 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/787755
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS May 25, 2010 Abandoned
Array ( [id] => 6121475 [patent_doc_number] => 20110077287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED MRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS' [patent_app_type] => utility [patent_app_number] => 12/787566 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10674 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077287.pdf [firstpage_image] =>[orig_patent_app_number] => 12787566 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/787566
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED MRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS May 25, 2010 Abandoned
Menu